Also known as MBDB, N-Methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine, 1-(1,3-Benzodioxol-5-yl)-N-methylbutan-2-amine
MBDB, also known as '''N-methyl-1,3-benzodioxolylbutanamine or as 3,4-methylenedioxy-N-methyl-α-ethylphenylethylamine, is an entactogen of the phenethylamine, amphetamine, and phenylisobutylamine families related to MDMA. It is known by the nicknames "Eden" and "Methyl-J'''".
~7 min read
MBDB, also known as '''N-methyl-1,3-benzodioxolylbutanamine or as 3,4-methylenedioxy-N-methyl-α-ethylphenylethylamine, is an entactogen of the phenethylamine, amphetamine, and phenylisobutylamine families related to MDMA. It is known by the nicknames "Eden" and "Methyl-J'".
==Use and effects== MBDB was first synthesized by pharmacologist and medicinal chemist David E. Nichols and later tested by Alexander Shulgin and described in his book, PiHKAL: A Chemical Love Story''. MBDB's dose, according to PiHKAL, is 180 to 210mg; the proper dosage relative to body mass seems unknown. Its duration is 4 to 8hours, with noticeable after-effects lasting for 1 to 3hours.
via Wikipedia infobox
via Wikidata · CC0
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).